Inogen, Inc. (INGN) vs Minerva Neurosciences, Inc. (NERV)
A side-by-side comparison of Inogen, Inc. and Minerva Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INGN
Inogen, Inc.
$5.80HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
NERV
Minerva Neurosciences, Inc.
$3.43HealthcareDelayed quote: Oct 6, 2026, 2:39 PM EDT
Total return — INGN vs NERV
growth of $100 · dividends reinvested · last 10yINGN -90.0% (-20.6%/yr)NERV -97.0% (-29.7%/yr)INGN compounded faster over this window
INGN NERV
INGN vs NERV: by the numbers
- •NERV is the larger company ($160M vs $157M market cap).
- •Both run net losses; NERV's is the smaller (0.00% vs -6.94% net margin).
Metrics side by side
Valuation
| Metric | INGN | NERV |
|---|---|---|
| P/S ratio | 0.44 | N/A |
| P/B ratio | 0.90 | N/A |
Profitability
| Metric | INGN | NERV |
|---|---|---|
| Gross margin | 48.89% | 0.00% |
| Operating margin | -8.45% | 0.00% |
| Net margin | -6.94% | 0.00% |
| ROE | -14.07% | N/A |
| ROIC | -13.94% | -38.56% |
Growth (annualized)
| Metric | INGN | NERV |
|---|---|---|
| Revenue CAGR (5Y) | 1.02% | N/A |
| Total return CAGR (5Y) | -32.83% | -22.14% |
Frequently asked
- How have INGN and NERV total returns compared?
- Over the past 10 years, INGN delivered -20.74% and NERV delivered -29.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.